國際資源(01051.HK)斥4,200萬美元認購基金有限合夥人權益
國際資源(01051.HK)公布,透過附屬Data Giant International Limited與普通合夥人訂立認購協議,以作為有限合夥人認購於Genesis Capital III LP基金中的有限合夥人權益,資本承擔額為4,200萬美元。
該基金主要對在中國處於成長期及成熟期科技相關實體的股權及股權相關證券進行直接或間接投資,以產生收入及資本升值。國際資源表示,通過利用現有的戰略及廣泛的資源以及基金管理團隊於科技、媒體及電訊行業的投資及基金營運的豐富經驗,認購事項將為集團帶來寶貴的投資機遇及更多財務回報。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.